Senegal Produces Africa-Made Sickle Cell Treatment as DREPAF Expands Access to Care
Senegal has begun local production of DREPAF, a generic hydroxyurea treatment for sickle cell disease, in what is being hailed as a major milestone for pharmaceutical production and healthcare access in Africa. The medicine is being produced by Senegalese …